Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: The dietary habit profile in European communities with different risk of myocardial infarction - The impact of migration as a model of gene-environment interaction project

Journal of Hypertension

Volumn 26, Issue 12, 2008, Pages 2303-2311

  Costanzo, Simona ^a   Di Castelnuovo, Augusto ^a   Zito, Francesco ^a   Krogh, Vittorio ^b   Siani, Alfonso ^c   Arnout, Jozef ^d   Cappuccio, Francesco P ^e   Miller, Michelle A ^e   Van Dongen, Martien ^f   De Lorgeril, Michel ^g   De Gaetano, Giovanni ^a   Donati, Maria Benedetta ^a   Iacoviello, Licia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g Lab Stress Cardiovasculaire P   (France)

Author keywords

Antihypertensive therapy; Awareness; Blood pressure; Europe; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; BELGIUM; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; DISEASE CONTROL; EATING HABIT; EUROPE; FEMALE; FOOD PREFERENCE; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MIGRATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM; BIOLOGICAL MODEL; CAUCASIAN; CLINICAL TRIAL; COMPARATIVE STUDY; FAMILY SIZE; FEEDING BEHAVIOR; GENETICS; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AWARENESS; BELGIUM; EMIGRATION AND IMMIGRATION; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY CHARACTERISTICS; FEMALE; FOOD HABITS; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, GENETIC; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS;

EID: 59849086009     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328311ce04     Document Type: Article

References (34)

1. Kearney PM,Whelton M, Reynolds K, Muntner P,Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H, Joffres M, et al. Hypertension and blood pressure levels in 6 European countries, Canada, and the US. JAMA 2003; 289: 2363-2369.
3. Baguet JP, Barone-Rochette G, Mallion JM. European Society of Hypertension Scienti?c Newsletter: hypertension and coronary heart disease. J Hypertens 2006; 24: 2323-2325.
4. Collins R, McMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-298.
5. KannelWB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-1576.
6. Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 356: 1955-1964.
7. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR,Giampaoli S, JoffresMR, et al. Hypertension treatment and control in ?ve European countries, Canada, and the United States. Hypertension 2004; 43: 10-17.
8. Erdine S. European Society of Hypertension Scienti?c Newsletter: update on hypertension management - how well is hypertension controlled in Europe? J Hypertens 2000; 18: 1348-1349.
9. Patel R, Lawlor DA, Whincup P, Montaner D, Papacosta O, Brindle P, Ebrahim S. The detection, treatment and control of high blood pressure in older British adults: cross-sectional ?ndings from the British Women's Heart and Health Study and the British Regional Heart Study. J Hum Hypertens 2006; 20: 733-741.
10. Fagard RH, Van den Enden M. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care. J Hum Hypertens 2003; 17: 681-687.
11. Fagard RH, Van Den Enden M, Leeman M,Warling X. Survey on treatment of hypertension and implementation of World Health Organization/ International Society of Hypertension risk strati?cation in primary care in Belgium. J Hypertens 2002; 20: 1297-1302.
12. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensi?cation, and control in Western Europe and the United States. Arch Intern Med 2007; 167: 141-147.
13. Iacoviello L, Arnout J, Buntinx F, Cappuccio FP, Dagnelie PC, de Lorgeril M, et al. Dietary habit pro?le in European Communities with different risk of myocardial infarction: the impact of migration as a model of gene- environment interaction. The IMMIDIET study. Nutr Metab Cardiovasc Dis 2001; 11 (Suppl 4):122-126.
14. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-1557.
15. Russo P, Lauria F, Loguercio M, Barba G, Arnout J, Cappuccio FP, et al. -344C/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. Am J Hypertens 2007; 20: 218-222.
16. Di Castelnuovo S, Quacquaruccio G, Arnout J, Cappuccio FP, de Lorgeril M, Dirckx C, et al. Risk factors and global risk of fatal cardiovascular disease are positively correlated between partners of 802 spouse pairs from different European countries: report from the IMMIDIET project. Thromb Haemost 2007; 98: 648-655.
17. Dean SC, Harper CE, Cappuccio FP, Rink E, Dirckx C, Arnout J, et al. The challenges of cross-national research in primary health care across Europe. Fam Pract 2005; 22: 1-6.
18. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 1993; 270: 354-359.
19. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-536.
20. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
21. Clinical Guidelines on the Identi?cation, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Institutes of Health Obes Res 1998; 6 (Suppl 2):51S- 209S.
22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
24. FriedewaldWT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. SAS Institute Inc. SAS/STAT user guide, version 8.2 forWINDOWS. Cary, North Carolina: SAS Institute Inc; 1989.
26. Schuit AJ, Wendel-Vos GC, Verschuren WM, Ronckers ET, Ament A, Van Assema P, et al. Effect of 5-year community intervention Hartslag Limburg on cardiovascular risk factors. Am J Prev Med 2006; 30: 237-242.
27. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187-1192.
28. Menotti A, Lanti M, Zanchetti A, Puddu PE, Cirillo M, Mancini M, Vagnarelli OT. Impact of the Gubbio population study on community control of blood pressure and hypertension. Gubbio Study Research Group. J Hypertens 2001; 19: 843-850.
29. Cuspidi C, Michev I, Meani S, Severgnini B, Sala C, Salerno M, et al. Lombardy Regional Section of the Italian Society of Hypertension. Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy. J Hum Hypertens 2003; 17: 541-547.
30. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, et al. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006; 24: 837-843.
31. Carolei A, Marini C, Di Napoli M, Di Gian?lippo C, Santalucia P, Baldassarre M, et al. High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998). First year's results. Stroke 1997; 28: 2500-2506.
32. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999- 2004. Hypertension 2007; 49: 69-75.
33. Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NR. Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 2006; 48: 853-860.
34. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25: 1491-1498.